Preclinical Research

  • The classic hallucinogen LSD for investigation of neurocircuity alterations related to its effects on alcohol preference
    PI: Sarah Mennenga, PhD
    Co-I/Project Mentor: Tanya Sippy, MD, PhD
    Sponsors: NYU Langone PRTP and MindMed, Inc.
  • The non-hallucinogenic LSD derivative, BOL-148/2-bromo-LSD, for investigations of its effects on alcohol preference and related neurocircuitry
    PI: Sarah Mennenga, PhD
    Co-I/Project Mentor: Tanya Sippy, MD, PhD
    Sponsors: CH TAC, NYU Langone PRTP, and MindMed, Inc.